MIRUM PHARMACEUTICALS INC (MIRM)

US6047491013 - Common Stock

26.39  +0.55 (+2.13%)

After market: 26.39 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
186.37M77.06M19.14M0.000.00
Cost Of Goods
47.04M12.37M1.90MN/AN/A
Gross Profit
139.34M64.69M17.24MN/AN/A
Operating Expenses
248.49M195.91M190.65M104.30M54.74M
Research and Development
102.61M106.84M131.43M81.61M42.99M
Selling, General, and Administrative Expenses
145.88M89.07M59.22M22.69M11.75M
Operating Income
-109.15M-131.22M-173.41M-104.30M-54.74M
Interest Income/Expense
-1.37M-11.22M-17.96M1.22M2.21M
Other Income/Expense
-2.82M370.00K-580.00K-190.00KN/A
Non Recurring Items
-49.08M0.00108.00MN/A0.00
Income Before Taxes
-162.42M-142.07M-83.95M-103.26M-52.53M
Income Tax
991.00K-6.41M40.00K10.00K20.00K
Net Income
-163.41M-135.67M-83.99M-103.27M-52.55M
EBITDA
-98.33M-127.98M-172.81M-103.99M-54.60M
 
Per Share Data
EPS Diluted Total Ops
-4.00-4.01-2.77-4.09-2.28
Non GAAP EPS
-3.97-4.02-6.35-4.08N/A
 
Statistics
Gross Profit Margin
74.76%83.95%90.07%N/AN/A
Profit Margin
-87.68%-176.06%-438.82%N/AN/A
Operating Profit Margin
-58.57%-170.28%-906.01%N/AN/A

All data in USD

Charts